Dr. Andrew Muir, MD
Claim this profileEmory Children's Center
Studies Type 1 Diabetes
Studies Cholangitis
11 reported clinical trials
14 drugs studied
Area of expertise
1Type 1 Diabetes
mIAA positive
IA-2A positive
ICA positive
2Cholangitis
Affiliated Hospitals
Clinical Trials Andrew Muir, MD is currently running
JAK Inhibitors
for Type 1 Diabetes
This trial is testing two medications, abrocitinib and ritlecitinib, which aim to reduce immune system activity. The study focuses on people who have been recently diagnosed with Stage 3 Type 1 Diabetes. These medications work by calming the immune system to prevent it from attacking insulin-producing cells in the pancreas.
Recruiting0 awards Phase 213 criteria
Linerixibat
for Cholestasis
This is an open-label, non-comparator, global, multi-center, long-term safety study for evaluating safety and tolerability of linerixibat in participants with cholestatic pruritus in primary biliary cholangitis (PBC) who participated in a prior clinical trial with linerixibat (BAT117123 \[NCT01899703\], 201000 GLIMMER \[NCT02966834\] (group 1) or 212620 GLISTEN \[NCT00210418\]) (group 2). All participants will receive open-label linerixibat for the duration of the study. The study duration is expected to last until the study's end or until linerixibat can be lawfully made available to participants. However, the total duration of study participation will vary by participant depending upon the time of entry relative to study end in their respective country.
Recruiting2 awards Phase 35 criteria
More about Andrew Muir, MD
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Andrew Muir, MD has experience with
- Placebo
- Linerixibat
- Screening And Monitoring For Type 1 Diabetes Risk
- NNC0361-0041
- Hydroxychloroquine
- CNP-104
Breakdown of trials Andrew Muir, MD has run
Type 1 Diabetes
Cholangitis
Liver Cirrhosis
Diabetes
Primary Biliary Cirrhosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Muir, MD specialize in?
Andrew Muir, MD focuses on Type 1 Diabetes and Cholangitis. In particular, much of their work with Type 1 Diabetes has involved mIAA positive patients, or patients who are IA-2A positive.
Is Andrew Muir, MD currently recruiting for clinical trials?
Yes, Andrew Muir, MD is currently recruiting for 5 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Andrew Muir, MD has studied deeply?
Yes, Andrew Muir, MD has studied treatments such as Placebo, Linerixibat, Screening and Monitoring for Type 1 Diabetes Risk.
What is the best way to schedule an appointment with Andrew Muir, MD?
Apply for one of the trials that Andrew Muir, MD is conducting.
What is the office address of Andrew Muir, MD?
The office of Andrew Muir, MD is located at: Emory Children's Center, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory Children's Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.